


If you've tried two or more antidepressants without finding relief, you may be living with treatment-resistant depression (TRD). At Boston Neurobehavioral Associates in Dartmouth, we now offer Spravato® (esketamine) — an FDA-approved nasal spray therapy designed to help when traditional medications haven't worked.
Location: Dartmouth only
Learn More
Spravato® (esketamine) is a prescription nasal spray that represents a significant advancement in depression care. It holds the distinction of being the first and only FDA-approved nasal spray specifically developed for adults battling treatment-resistant depression (TRD).
It works differently from traditional antidepressants by targeting glutamate pathways in the brain to help improve mood and relieve symptoms when other medications haven't worked.

Schedule a consultation with our clinical team to review your history and determine if Spravato® is right for you.
Receive treatment in our monitored clinic setting. Sessions last approximately two hours including observation time.
Follow your personalized treatment plan — typically twice weekly to start, then tapering down as you improve.
We are fully REMS-certified to administer Spravato® in compliance with FDA safety standards.
Most major insurance plans, including Medicaid, are accepted for Spravato® treatment.
Our caring team ensures your comfort, privacy, and well-being at every step of treatment.

Is It Right For You?
You Need Spravato® If:
Spravato® is not for everyone. Certain health conditions or a history of substance misuse may mean it's not the right fit. Our care team will review your full medical history to ensure your safety.
Boston Neurobehavioral Associates — Dartmouth, MA